Cerebral ischemia induces a rapid and dramatic up-regulation of tumor necrosis factor (TNF) 
INTRODUCTION
Tumor necrosis factor (TNF), a pleiotropic cytokine produced during the physiological response to infection, injury, or ischemia, has been implicated in disease pathophysiologies of the central nervous system (CNS) such as cerebral meningitis, cerebral malaria, multiple sclerosis, Alzheimer's disease, HIV encephalopathy, and cerebral ischemia. A large body of evidence suggests that the relative overproduction of TNF during cerebral ischemia amplifies and extends the severity of cell death during brain ischemia. The expression of TNF protein and mRNA are stimulated during cerebral ischemia, with peak protein expression occurring by 6 hr after the onset of ischemia (1), or shortly thereafter (2) . In animal models of head injury, TNF synthesis is also increased, possibly secondarily to the onset of cerebral ischemia (3) (4) (5) (6) . Cerebral hypoxia-ischemia increased TNF mRNA in perinatal rat brain (7) , and an early and marked increase of TNF in neuronal somata has been observed following surgical injury (5) .
As in other biological conditions in which low levels of TNF can be beneficial, but higher levels are injurious (8) , excessive intracerebral TNF in the context of cerebral ischemia is damaging. Therapeutic implications are suggested by the attenuation of brain-damaging ischemic sequelae following administration of anti-TNF antibodies or receptor constructs. Repeated 765 intracerebroventricular administration (9) , or intracortical injection of anti-TNF antibodies (10) significantly limited the volume of ischemic brain damage. The administration of soluble type 1 TNF receptors (TNFRs) significantly protected against the development of brain infarction in SHR rats (11) . Topical application of a dimeric polyethylene glycol-linked TNFR1 also significantly protected against focal cerebral infarction in BALB/c mice (12) . Evidence for a protective role of TNF in cerebral ischemia was observed in genetically engineered knock-out mice rendered devoid of TNF receptors, which develop significantly larger cerebral infarctions than wild-type controls (13) . Considered together, these results indicate that in response to ischemia, low levels of TNF may be beneficial, but excessive production of the cytokine is deleterious.
TNF can be produced by many cells, including lymphocytes, natural killer cells, endothelial cells, mast cells, smooth muscle cells, etc. (14, 15) . In the CNS, microglia (16, 17) , astrocytes (18) (19) (20) and choroid plexus ependymal cells (21) 
MATERIALS AND METHODS

Surgery
Permanent focal cerebral ischemia was performed as described elsewhere (33, 34) . Briefly, male Lewis rats were anesthetized with ketamine and both common carotid arteries were exposed and ligated. The entire temporalis muscle was removed and the bone adjacent to the zygomatic arch was drilled to open the surface of the brain. The middle cerebral artery was permanently occluded by electrocoagulation. After that, the contralateral common carotid artery (CCA) was occluded for 1 hr while the ipsilateral one was permanently ligated. Temperature was maintained at about 37°C. After 1 hr, the temporary occlusion of the CCA was removed and the neck and head incisions were closed. The animal was then allowed free access to food and water.
Tissue Preparation At different times (2-24 hr) after the onset of MCA ocdusion, animals were deeply anesthetized and perfused as described by Breder et al. (35) . Briefly, 30 ml of saline (pH 7.4) was perfused transcardially followed by 100 ml of 4% formaldehyde in phosphate-buffered saline (PBS) (pH 6.5) and 100 ml of the same fixative at pH 8.5 
Immunocytochemistry
Sections were incubated in a solution containing 0.3% H202 and 0.3% Triton X-100 in 0.01 M PBS for 10 min at room temperature. Washed sections were then incubated in a blocking solution containing 1% BSA, 5% normal goat serum, and 0.3% Triton X-100 in 0.01 M PBS for 1 hr at room temperature (RT) and then incubated for 24 hr at 4°C with a 1:100 dilution of the monoclonal hamster anti-murine TNF or monoclonal hamster anti-mouse TNF receptor (p55 or p75) antibodies (Genzyme) with 0.3% Triton X-100 and 0.1% BSA and 3 % normal serum in 0.01 M PBS. Washed sections were incubated for 1-2 hr RT in 0.5% biotinilated anti-hamster IgG (Vector Labs) or biotinilated anti-Armenian hamster IgG (Jackson Immunoresearch Lab) for 1-2 hr. The reaction product was vizualized with 0.01% hydrogen peroxide and 0.05% diaminobenzidine (DAB) as a chromogen. Sections were then processed for light microscopy by standard methods.
For detection of possible colocalization of TNF and TNFR immunoreactivity (IR) with particular cell types, double-label immunofluorescence was used. After incubation in a blocking solution, brain sections were incubated in a mixture of the diluted primary antibodies: hamster anti-TNF, or anti-pS5 or anti-p75 with rabbit anti-glial fibrillary acidic protein (GFAP) (DAKO) or rabbit anti-neurofilament 200 (NF200). As secondary antibodies, a mixture of a rhodamineconjugated goat anti-hamster IgG and fluorescein-conjugated goat anti-rabbit IgG (Vector Lab) was used. After 2 hr of incubation with the secondary antibodies, the sections were processed for microscopic analysis with epifluorescence according to standard processes. Specificity was determined by incubation of tissue without primary antibodies or by preabsorption of anti-TNF antibodies with recombinant mouse TNF (Genzyme).
TUNEL Staining
We used a terminal deoxynucleotidyltransferase (TdT)-mediated dUTP-biotin nick end-labeling (TUNEL) method (ApopTag kit, Oncor) for specific staining of DNA fragmentation in apoptotic cells. Ten micrometer-thick brain sections obtained as described above were post-fixed in ethanol-acetic acid (2:1) for 5 min at -20°C and washed with 0.01 M PBS three times for 5 min. After digesting protein in tissue sections using proteinase K (20 ,ug/ml) for 15 min at room temperature, and quenching endogenous peroxidase activity with 1% H202 in PBS for 5 min at room temperature, slides were placed in equilibration buffer and then incubated with workingstrength TdT enzyme for 1 hr at 370C. After 10 min of incubation in stop/wash buffer and washing in PBS, sections were incubated for 30 min with anti-digoxigenin-peroxidase, washed again, and reacted with diaminobenzidine. As a negative control, we used section incubated with a reaction buffer and distilled water instead of TdT enzyme. Double immunofluorescent labeling was performed on the same brain sections after the visualization of TUNEL-positive cells.
RESULTS
Neuronal and Glial Expression of TNF Focal cerebral ischemia involving permanent MCA occlusion induced the widespread appearance of TNF-like immunoreactivity (IR) within the ischemic core as well as the surrounding hypoperfused penumbra within 6 hr after the onset of ischemia (Fig. 1A, B) . The absolute number of TNF-positive cells per unit area was significantly higher within the penumbra than in the ischemic core, principally attributable to greater cell death within the volume of the most severely compromised blood flow. Minimal or nondetectable TNF IR was observed at 2 hr after the onset of ischemia within the developing infarct. Early after ischemia, the contralateral cortex showed no TNF IR ( Fig. 1 C) (GFAP) cell markers The majority of cells expressing TNF within the ischemic cortex (A, red filter) also showed NF200 IR (B, green filter). However, the dense network of TNF-positive fibers showed a negative correlation with this neuronal marker, suggesting that they represent glial processes. GFAP-positive astrocytes within the hypoperfused penumbra (D, green filter) also show TNF IR (C, red filter).
In addition, some cells clearly demonstrated punctate TNF IR at the cell margin (Fig. 1G) , probably reflecting membrane-associated TNF. Double-label fluorescence immunocytochemistry showed that virtually all neurons in the ischemic core and a majority of those in the adjacent penumbra were TNF immunoreactive ( Fig. 2A, B) . Separate exposures of the same field show the colocalization of TNF (red filter) and the neuronal marker NF200 (green filter) IR within the ischemic core. In addition to the colocalization of NF200 IR and TNF IR in neuronal cell bodies, a dense network of TNF-positive filaments ( Fig. 2A ) that are not NF200 immunoreactive (Fig. 2B) , are also readily visible; presumably these represent glial processes. In the ischemic penumbra, most hypertrophic astrocytes expressed both GFAP IR and TNF IR ( Fig. 2C, D ; TNF IR, red filter and GFAP IR, green filter). It is noteworthy that almost no astrocytic cell bodies were observed within the ischemic core. The above described distribution of TNF IR 769 was not significantly different at 24 hr, although the volume of severely damaged brain tissue (ischemic core) was larger and had taken on a more spongiform appearance that demonstrated fewer intact cell profiles. At 24 hr, the density of TNF IR within cell bodies in the ischemic penumbra was slightly lower than at 6 hr after MCA occlusion, but the appearance of punctate and filamentous TNF IR within penumbra was more prominent.
Dense TNF IR was detected near the surface of the ischemic brain ( Fig. 3A; 4A, B) . Doubleimmunostaining revealed the colocalization of TNF IR and GFAP IR within the outermost part of the cortex (Fig. 3A, B) . High-resolution photomicrographs clearly show that distinct cellular elements contribute to the TNF JR in this area, i.e., microglia (Fig. 4A ) and astrocyte end-feet (Fig. 4B ). This distribution of TNF IR was not detected in the contralateral hemisphere (Fig. 4C) . MCA occlusion induced the appearance of perivascular TNF IR in the subarachnoid space (arrow on Fig. 3A ) and on the surface of brain capillaries within the ischemic cortex (Figs. 3C and 5A ). CNS capillaries, in contrast to large brain vessels, are almost completely surrounded by astrocytic endfeet (Fig. 3D) . Just outside the immediate perivascular zone of the small cortical vessels, GFAP JR was co-extensive with TNF JR (Fig. 3C, D) . The TNF IR on larger brain vessels within the subarachnoid space, however, did not colocalize with GFAP IR (Fig. 3A, B , arrows). Transected brain vessels also revealed dense TNF IR within the endothelial layer (Fig. SB) ; no staining was observed in negative control tissues incubated with the absence of TNF antibodies (Fig. 5C ).
Inflammatory Cell Expression of TNF Focal brain ischemia induced prominent PMN infiltration ipsilateral to the infarction. Most infiltrating PMNs detected 24 hr after the onset of ischemia were located in the subarachnoid space. They were also identified within the ischemic core (Fig. 6A ). All such marginated PMNs expressed diffuse cytoplasmic TNF IR with more dense punctate TNF IR at the cell surface (Fig. 6C) . In addition, choroid plexus cells in the lateral ventricle ipsilateral to the MCA occlusion expressed a low to moderate degree of cytoplasmic TNF IR.
Expression of TNF Receptors
In normal brain, and within cortex contralateral to the infarction, p55 JR appeared as rare, irregular islets of lightly immunoreactive fibers of different lengths and thicknesses. At 4-6 hr after permanent MCA occlusion, a dramatic increase of immunoreactive p55 protein expression was observed within the ipsilateral ischemic cortex, resulting in a significantly larger (5-to 10-fold) number of p55-positive patches exhibiting much more dense filamentous immunoreactivity (Fig. 7A, B) within a more continuous network of fine filamentous and punctate p55 IR (Fig. 7C) . Neuronal cell bodies within the ischemic cortex also expressed low to moderate p55 immunoreactivity at this timepoint. The level of protein expression and the number of p55 immunoreactive cells increased further 24 hr after the onset of ischemia (Fig. 7D) . The immunoreactive product was predominantly localized at the cell surface, rather than within the cytoplasm.
The above described "patchy' distribution of p55 immunoreactivity was not observed in p75 immunocytochemistry; no p75 JR was observed in samples taken at 6 hr after MCA occlusion. By 24 hr, however, many neurons within the ischemic core and within the proximal penumbral zone expressed low to moderate levels of p75 IR (Fig. 7F) ; no such p75-positive profiles were detected in the contralateral cortex (Fig. 7E) . In addition to cell-associated p75 IR, the ipsilateral cortex in the zone of greatest ischemia also expressed punctate DAB reaction product localized at or near the cell surface (Fig. 7G, H) . MCA occlusion also induced the appearance of dense, specific p55 and p75 IR at the inner surface of transacted brain vessels (Fig. 8) . In contrast to TNF expression in brain vessels (see Fig. SB ), pS5 and p75 immunoreactive products appear to localize at the endothelial cell surface rather than in the cytoplasm (Fig. 8A, B) . Immunocytochemical analysis of brain vasculature in control (no stroke) animals did not show TNF receptor protein-associated immunoreactivity (Fig. 8C) .
In double immunofluorescent-stained material from the core and penumbra sampled at 24 hr after the onset of ischemia, both TNF receptors colocalized with NF200 IR. No correlation of immunoreactive p55 or p75 proteins with GFAP JR was detected in association with hypertrophic astrocytic cell bodies in the ischemic penumbra, nor was it found within the ischemic core. p55 and p75 immunoreactivity was associated with GFAP IR, but not with NF200 IR, at the cortical surface, in association with brain capillary walls, and on the ventricular surface. Non capillary brain vessels also expressed p55 and p75 IR at their parenchymal surface, but there was no GFAP-positive staining associated with these larger vessels.
Colocalization of Neuronal TNF IR with TUNEL Labeling
To study whether TNF expression correlates with cell death, we performed an additional experiment with triple staining (TNF and NF200 double-immunofluorescence plus TUNEL labeling). Within ischemic cortex, only those neurons that exhibited apoptotic changes also expressed TNF IR (Fig. 9) . Cells with green fluorescence represented normal neurons; TUNELpositive apoptotic neurons had brown nuclei (Fig. 9A) . Yellowish staining of the cytoplasm of apoptotic neurons was a result of double exposure of NF200 green fluorescence and brightfield light microscopy for TUNEL-positive cells. Cells with TNF IR were red (Fig. 9B) (3), and with the observation that TNF mRNA expression in rat cerebral cortex was maximal between 6 and 12 hr after MCA occlusion (2) . An earlier time course was shown by Buttini et al.
(1), during which the peak level of TNF mRNA expression was at 3 hr after the onset of ischemia.
In addition to neurons, several types of activated microglial cells express TNF IR in association with focal cerebral ischemia. Transient ischemia (36) (37) (38) , and soma-induced seizures (39) produce rapid (within [1] [2] [3] [4] hr) activation of microglia which is most prominent adjacent to neurons that were destined to die (36, 39) . [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] hr after the onset of ischemia, we found here that virtually all activated microglial cells were in close proximity to TNF-expressing neurons. Moreover, we have found a straight correlation between TNF expression and apoptosis within particular neurons at 24 hr after the MCA occlusion: only TUNEL-positive apoptotic neurons expressed TNF IR. These findings are in agreement with the classical viewpoint that neurodegenerative events can signal resting microglia, transforming them into an active form. Although no direct TNF toxicity on neurons was shown (2, 9, 40, 41) , there are several observations that TNF can act selectively, destroying diseased cells or those treated with protein synthesis inhibitors (42, 43) , with little effect on normal cells (ref. from 44) . Thus, as TNF increases during ischemia, brain damage increases (9, 10) .
In response to focal ischemia, some cells displayed a patchy distribution of TNF IR restricted to the cell margin. The multifunctional activities of TNF are thought to be mediated through two molecular forms-a 17-kD mature form and a transmembrane 26-kD precursor protein. TNF observation is in agreement with other experiments using cultured astrocytes. For instance, TNF mRNA expression is markedly elevated in response to exogenous lipopolysaccharide (LPS) (20) . Furthermore, the TNF produced by LPSstimulated astrocyte cultures has been shown to be cytotoxic for oligodendrocytes (48) . It has also been reported that reactive astrocytes from the brains of patients with multiple sclerosis are positive for TNF IR (49) . Our visualization of dense, patchy TNF IR at neuronal cell margins might represent either TNF within the end-feet of reactive astrocytes which intimately surround neuronal cell bodies, or neuron-associated transmembrane TNF, or both.
The leukocyte infiltration that we observed by 24 hr after the onset of ischemia is a wellknown hallmark of CNS inflammation. In the case of brain ischemia, this process is led by polymorphonuclear leukocytes. Infiltration of the brain parenchyma by PMNs from the circulation has been demonstrated in several different animal models of stroke (50, 51) , and specific adhesion molecules (e.g., ICAM-1, ICAM-2, and ELAM-1) responsible for leucocyte infiltration have been defined. (31, 36) . The absence of p55 IR and p75 IR within GFAPpositive cell bodies ipsilateral to the induced stroke has several possible explanations: (a) a lack of TNF receptor expression by astrocytes during ischemia; (b) a low level of expression that was undetected by double immunofluorescence; and (c) subcellular distribution of receptor proteins via astrocytic processes to the end-feet regions. A combination of the latter two explanations seems consistent with the lack of GFAP/ TNFR double-positive cell bodies despite prominent colocalization of p55 and p75 IR with GFAP IR on the brain and ventricular surfaces, as well as on the cortical capillaries, where astrocytic end-feet form an enveloping layer.
The appearance of both TNF receptors on the inner surface of brain vessel as well as abundunt punctate p55 IR and, to a lesser extent, p75 IR product within ischemic cortex after MCA occlusion might also reflect the extensive induction of soluble TNF receptors. This suggestion is in agreement with data showing that soluble receptors for TNF are highly inducible and can prevent the adverse pathologic sequelae caused by the high level of TNF production in lethal sepsis (59) , trauma (60) , and stroke (9, 11, 12) . TNFRs are also constitutively shed in substantial amounts in vivo, thus plausibly regulating TNF activity (61) . The granule-and dot-like p55 and p75 immunoreactivity we observed during stroke may be the result of increased TNF receptor shedding. The appearance of p55 and p75 immunoreactive granules on the cell surface might reflect not only the up-regulation of membrane-associated receptor expression in response to the MCA occlusion but also receptor aggregation in response to ligand binding (62) .
The biological role of TNF in cerebral ischemia is probably dependent upon a balance in signaling via both p55 and p75, but it is not yet clear what the consequences of these molecular interactions will be for the ischemic brain. It conditions (63, 64) . Some authors have found no direct TNF toxicity on neurons (2, 9, 40, 41) , but other observations suggest that TNF can act selectively, destroying diseased or otherwise stressed cells (42, 43) , while having no effect on normal cells (44 (10) . Inhibition of TNF protects against the development of cerebral edema (9, 65) and soluble TNFR1 administration is neuroprotective (9, 11, 12) . It now appears that the enhanced production of TNF and its receptors on glial, neuronal and peripheral inflammatory cells occupies a pivotal role in mediating the injurious effects of brain ischemia.
